Ocera Therapeutics Announces Change in Executive Team
04 mai 2015 08h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., May 4, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), today announced that Rajiv Patni, M.D., chief development officer, has decided to step down from his position...
Ocera Reports Pipeline Progress and First Quarter 2015 Financial Results
30 avr. 2015 08h05 HE
|
Ocera Therapeutics, Inc.
Strong Enrollment in STOP-HE Trial
Conference Call and Webcast at 10:00 a.m. ET
PALO ALTO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage...
Ocera Therapeutics to Report Pipeline Progress and First Quarter 2015 Financial Results
22 avr. 2015 16h43 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Completes Interim Analysis of OCR-002 in Phase 2b STOP-HE Study for the Treatment of Acute Hepatic Encephalopathy
01 avr. 2015 17h03 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., April 1, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Reports Fourth Quarter and Full Year 2014 Financial Results
11 mars 2015 16h01 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Therapeutics to Announce Fourth Quarter and Full Year 2014 Financial Results
02 mars 2015 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Therapeutics to Present at 35th Annual Cowen and Company Health Care Conference
23 févr. 2015 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Announces Preliminary Topline Results From Phase 2a Investigator-Sponsored Study of OCR-002
18 févr. 2015 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX) today announced preliminary topline results from a Phase 2a investigator-sponsored study evaluating the...
Ocera Therapeutics Promotes Michael Byrnes to Chief Financial Officer
03 déc. 2014 08h01 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Dec. 3, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical-stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Reports Third Quarter 2014 Financial Results
13 nov. 2014 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...